| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,187 |
6,165 |
$287K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,874 |
3,954 |
$173K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,652 |
3,985 |
$132K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
8,731 |
7,236 |
$46K |
| 99406 |
|
1,893 |
1,396 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
143 |
125 |
$9K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
2,460 |
1,633 |
$6K |
| 99442 |
|
180 |
143 |
$5K |
| 99307 |
|
2,056 |
690 |
$4K |
| 80305 |
|
750 |
415 |
$4K |
| 99490 |
Ccm add 20min |
1,582 |
1,141 |
$3K |
| 99306 |
Prolong nursin fac eval 15m |
210 |
172 |
$3K |
| 99305 |
|
305 |
230 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
544 |
232 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
49 |
42 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
34 |
34 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
283 |
192 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
132 |
124 |
$1K |
| 90688 |
|
85 |
74 |
$718.56 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
18 |
$623.22 |
| 99441 |
|
17 |
17 |
$557.01 |
| 99356 |
|
246 |
116 |
$531.83 |
| 90632 |
|
288 |
101 |
$463.95 |
| 90686 |
|
174 |
86 |
$451.28 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
729 |
428 |
$324.60 |
| 20610 |
|
17 |
13 |
$318.32 |
| 96127 |
|
72 |
65 |
$167.76 |
| 99334 |
|
76 |
37 |
$127.27 |
| 69210 |
|
86 |
59 |
$124.92 |
| G0127 |
Trimming of dystrophic nails, any number |
53 |
38 |
$83.17 |
| 11721 |
|
41 |
38 |
$53.52 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
126 |
124 |
$33.42 |
| 99439 |
|
19 |
14 |
$9.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
14 |
12 |
$0.91 |
| G0008 |
Administration of influenza virus vaccine |
58 |
33 |
$0.00 |